✦ LIBER ✦

386 Phase I study of the vascular disrupting agent (VDA) ombrabulin (Ob) in combination with taxanes (T) and platinum salts (PS) in patients (pts) with advanced solid tumors

✍ Scribed by J.C. Soria; R. Bahleda; B. Besse; C. Sessa; R.g. Calderone; L. Gianni; G. Del Conte; A. Perotti; B. Daglish; C. Oprea

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I and pharmacologic study of the

✍ A. S. T. Planting; P. Sonneveld; A. van der Gaast; A. Sparreboom; M. E. L. van d 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 253 KB

607 POSTER Impressive anti-tumor activit

✍ M. Beeram; J.S. De Bono; E.K. Rowinsky; P. O'Rourke; A. Ricart; L.A. Hammond; A. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB

346 POSTER CBP501, a novel cell cycle G2

✍ M.S. Gordon; J.P. Eder; D.S. Mendelson; E. Wasserman; W. Sutherland; T. Kawabe; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB

35 POSTER A Phase I trial of a combinati

✍ G. Dy; G. Croghan; A. Furth; J. Reid; L. Hanson; M. Roos; A. Tan; A. Adjei 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 134 KB